| 本文已被：浏览 2792次 下载 2025次 |
码上扫一扫！ |
| 原发性胆汁性肝硬化患者外周血单个核细胞趋化因子受体的表达及临床意义 |
| 韩志君,吴传勇,蒋廷旺,唐裕杰,周晔,陈燕,谷明莉,邓安梅*,仲人前* |
|
|
| (第二军医大学长征医院实验诊断科,全军医学免疫诊断中心,全军临床免疫重点实验室,上海 200003) |
|
| 摘要: |
| 目的:初步探讨趋化因子受体(chemokine receptor)与原发性胆汁性肝硬化(PBC,primary biliary cirrhosis) 发生发展的关系。方法: 采用实时荧光定量PCR和流式细胞术,分别从基因转录和蛋白表达水平检测60例PBC、60例乙型肝炎肝硬化患者（疾病对照）和60例健康对照者的外周血单个核细胞(PBMCs)中CCR1、CCR3和CCR5的表达;生化常规测定PBC 患者和健康对照者的总胆红素(TBIL)、γ-谷氨酰基转移酶(γ-GT)水平,分析它们与趋化因子之间的相关性。结果:PBC患者PBMCs中的CCR1、CCR3、CCR5的mRNA和蛋白表达均明显低于健康对照组和疾病对照组(P＜0.05),而疾病对照组和健康对照组PBMCs中CCR1、CCR3、CCR5 mRNA和蛋白表达无统计学差异(P>0.05);PBC患者Ⅲ、Ⅳ期PBMCs中的CCR1、CCR3、CCR5的mRNA 和蛋白表达较Ⅰ、Ⅱ期明显降低(P＜0.05);PBC患者CCR1蛋白表达水平与TBIL水平显著负相关(r=- 0.445,P<0.01),与γ-GT无线性相关关系(r=-0.230,P>0.05);CCR3蛋白表达水平与TBIL水平无线性相关关系(r=-0.173,P>0.05),与γ-GT水平负相关(r=-0.295,P<0.05);CCR5蛋白表达水平与TBIL、γ-GT水平均负相关(r=-0.531,P<0.01;r=-0.665,P<0.01)。结论:CCR1、CCR3、CCR5的表达与PBC的发生发展存在一定的相关性,可能参与了PBC的调控机制,为PBC的诊断和预防提供了新线索。 |
| 关键词: 胆汁性肝硬化 趋化因子受体 流式细胞术 单个核细胞 |
| DOI：10.3724/SP.J.1008.2009.0142 |
| 投稿时间：2008-07-08修订日期：2008-07-30 |
| 基金项目:国家高科技研究发展计划(“863”计划,2006AA02Z496),国家自然科学基金(30671840、30772017),上海市科学技术委员会优秀学科带头人基金(07XD14013). |
|
| Expression and clinical significance of chemokine receptor in peripheral blood mononuclear cells in patients with primary biliary cirrhosis |
| HAN Zhi-jun,WU Chuan-yong,JIANG Ting-wang,TANG Yu-jie,ZHOU Ye,CHEN Yan,GU Ming-li,DENG An-mei*,ZHONG Ren-qian* |
| (Department of Laboratory Medicine,Changzheng Hospital,Second Military Medical University,PLA Medical Immuno-diagnosis Center,Key Laboratory of Clinical Immunology of PLA,Shanghai 200003,China) |
| Abstract: |
| Objective:To investigate the relationship of chemokine receptor with the development and progression of primary biliary cirrhosis (PBC). Methods: Real-time PCR and flow cytometry were used to examine the mRNA and protein expression of chemokine receptor 1 (CCR1),CCR3 and CCR5 in the peripheral blood mononuclear cells (PBMCs) of 60 patients with PBC,60 patients with hepatitis B-related cirrhosis, and 60 normal controls. Total bilirubin (TBIL) and γ-glutamyltransferase (γ-GT) levels were determined in the patients with PBC and normal controls,and their correlation with chemotactic factors was also analyzed. Results: Both the mRNA and protein expression levels of CCR1,CCR3 and CCR5 in the PBMCs were significantly lower in PBC patients than those in the other two groups (P<0.05), and there were no significant differences between the latter two groups. The mRNA and protein levels of CCR1,CCR3 and CCR5 were significantly lower in patients with stage Ⅲ and Ⅳ PBC than those with stage Ⅰ and Ⅱ PBC. CCR1 protein expression was correlated with TBIL levels in PBC patients(r=- 0.445,P<0.01), but not with γ-GT(r=-0.230,P>0.05). CCR3 protein was not linearly correlated with TBIL level (r=-0.173,P>0.05),but was correlated with γ-GT(r=-0.295,P<0.05). Expression of CCR5 protein was negatively correlated with both TBIL and γ-GT levels(r=-0.531,P<0.01; r=-0.665,P<0.01). Conclusion: CCR1,CCR3 and CCR5 expression is associated with the development and progression of PBC; they may be involved in the regulatory mechanism of PBC,which may cast new lights on the diagnosis and prevention of PBC. |
| Key words: biliary liver cirrhosis chemokine receptors flow cytometry mononuclear cells |
